Blog

Via: https://www.biospace.com/article/diversity-makes-clinical-trial-recruitment-easier-and-outcomes-better/ Published: Jun 22, 2022 By Gail Dutton   Decentralized clinical trials may cost more upfront, but can have huge returns on the back end, according to speakers at Informa Connect’s Decentralized Clinical Trials meeting. The reason is that by expanding the diversity of trial participants, sponsors are

We are delighted to announce that R&D Partners has joined Acacium Group, the leading global healthcare, and life sciences solutions partner. Acacium Group is dedicated to offering staffing, managed services, and innovative delivery models to the life sciences industry, and to health and social care

Published: May 31, 2022 By Vanessa Doctor, RN VIA: https://www.biospace.com/article/bristol-myers-squibb-novartis-and-roche-cancer-drugs-get-fda-nod/   The long weekend saw three established drugs developed by Bristol Myers Squibb, Novartis and Roche score new approvals from the U.S. Food and Drug Administration. Opdivo Now a First-Line Therapy for Esophageal Squamous Cell Carcinoma

Via: https://www.biospace.com/article/cutting-commutes-and-adopting-ai-how-covid-19-has-changed-the-biopharma-industry-/?s=62 Published: Mar 09, 2022 By Hannah Chudleigh As the COVID-19 pandemic approaches its second anniversary in North America, the medical industry looks much different than it did just two years ago. Health and safety protocols have changed drastically, economies are still shifting and political

Via: https://www.biospace.com/article/biospace-launches-2022-hotbed-maps-to-highlight-thriving-life-sciences-clusters/ Published: Jan 18, 2022 By Heather McKenzie Featuring nine of the most important regions in the life sciences industry, BioSpace’s Hotbed Maps are the guide employees and investors across the sector look to in order to chart its trajectory. The unique, original watercolor artistry

Via: https://www.biospace.com/article/clinical-catch-up-january-10-14/ Published: Jan 17, 2022 By Mark Terry Heading into the middle of January, companies announced plenty of new clinical trial news. Here’s a look. COVID-19-Related Ocugen announced that its development partner, India’s Bharat Biotech, published positive data from a Phase II trial of the vaccine candidate

Via: https://www.biospace.com/article/life-sciences-companies-expand-operations-across-the-globe/ Published: Dec 17, 2021 By Alex Keown As 2021 nears an end, biopharma companies are eying the establishment of new toeholds and facilities across the globe that will bolster their commercial and manufacturing strategies. BioSpace rounds up some of the latest announcements. Pfizer Builds

Via: https://www.biospace.com/article/omicron-is-worrisome-but-delta-is-a-problem-right-now-and-other-covid-19-stories/ Dec 03, 2021 By Mark Terry Two years into the COVID-19 pandemic and countries are reporting what might be called the fourth wave of rising cases, driven mainly by the Delta variant, although Omicron has everybody concerned. Here’s a look. Omicron Variant At Least

Via: https://www.biospace.com/article/biotech-companies-are-expanding-the-frontiers-of-engineered-cell-therapy-/ Published: Nov 11, 2021 By Maggie Chen The plasticity of a cell is one of its quietly profound advantages – picture cells glowing from an extraneous DNA vector incorporated into the genome or cells that acquire newfound targeting abilities to find and kill problematic

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca has submitted a request to the US Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) for AZD7442, its long-acting antibody (LAAB) combination, for prophylaxis of symptomatic COVID-19. If granted, AZD7442 would be the first LAAB to receive an EUA

Via: https://www.biospace.com/article/exciting-clinical-news-out-of-the-european-society-for-medical-oncology-congress-2021 |Published: Sep 17, 2021 By Mark Terry Biopharma companies big and small are presenting exciting clinical studies at the European Society for Medical Oncology Congress 2021. Here’s a look at just some of those highlights: Amgen announced the first combination study results from the Phase Ib/II

Via: https://www.biospace.com/article/covid-19-us-expected-to-recommend-boosters-and-more/ Published: Aug 17, 2021 By Mark Terry What’s Next for COVID-19? All Signs Point to Boosters As COVID-19 surges to earlier pandemic levels in the U.S., federal health officials are expected to authorize a third booster shot eight months after receiving the second of

via: https://www.biospace.com/article/noting-delta-variant-pfizer-biontech-plan-to-ask-fda-for-eua-for-booster-shot/ Published: Jul 09, 2021 By Mark Terry Pfizer and BioNTech report a plan to request Emergency Use Authorization (EUA) for third booster shots for their COVID-19 vaccine. The two companies cited initial data from a clinical trial that showed a booster dose given six months

via: https://www.biospace.com/article/new-ceos-named-at-two-top-pharma-companies Published: Jul 08, 2021 By Vanessa Doctor, RN Two chief executive officers (CEOs) were named to biotech and pharmaceutical companies today. Boston-based oncology company Scorpion Therapeutics has announced the appointment of a new chief executive offer to help drive the firm’s cancer care programs. Dr. Axel Hoos joins the company

Novartis today announced the launch of More Than Just Words, a multiyear commitment to promote health equity in breast cancer care, where there is significant unmet need. Black women under the age of 35 are diagnosed with breast cancer at twice the rate of white

COVID-19-Related Biophytiscompleted recruitment of 155 patients to its COVA Phase II/III trial of Sarconeos in COVID-19 patients. This will allow the independent Data Monitoring Committee to run its second interim analysis. Sarconeos is an oral, small molecule being developed for sarcopenia in a Phase II trial,

via: https://www.inc.com/anis-uzzaman/top-business-technology-trends-in-2021.html By: Anis Uzzaman, General Partner and CEO, Pegasus Tech Ventures 2020’s Covid-19 pandemic has helped us all become acquainted with uncertainty. Companies are in a hurry to develop new digital capabilities in an effort to build resilience and retool for the post-pandemic world. Here

2020 is almost over but before we wave goodbye, R&D Partners wanted to give back to charities near and dear to us. We asked our employees to pick a foundation and make a donation. Here’s a list of all the amazing places we were able

Via: https://www.biospace.com/article/u-s-government-banks-on-vaccines-from-multiple-companies-to-end-pandemic/ Published: Dec 09, 2020 By Alex Keown The U.S. Food and Drug Administration (FDA) is on the cusp of approving the first vaccines against the novel coronavirus, delivering a potential end to the pandemic. Although vaccines will be available pending approval, there are questions

The Nobel Prize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing. They discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. Using these, researchers can change the DNA of animals, plants

Via: https://www.biospace.com/article/astrazeneca-expands-phase-iii-covid-19-vaccine-trial-into-the-u-s-/ AstraZeneca announced that its Phase III clinical trial of its COVID-19 vaccine  candidate, AZD1222, is expanding into the U.S. It will be dubbed D8110C00001 and is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The

VIA: https://scitechdaily.com/rare-boomerang-earthquake-tracked-by-scientists-in-the-ocean-for-the-first-time By IMPERIAL COLLEGE LONDON Scientists observed a ‘boomerang’ earthquake along Atlantic Ocean fault line, providing clues about how they could cause devastation on land. Earthquakes occur when rocks suddenly break on a fault – a boundary between two blocks or plates. During large earthquakes,

Are you in a leadership position in your company right now? Or do you aspire to be in that position someday? No matter where you are, these qualities can be worked on right now. If you want to be a good leader, they’re essential to

Sanofi Pasteur, the vaccines business unit of Paris-based Sanofi, and Lexington, Massachusetts-based Translate Bioannounced the expansion of an existing collaboration to develop mRNA vaccines for infectious diseases. The original deal was entered in 2018. Under the new deal expansion, Sanofi will pay Translate Bio $425 million up

The rapid advancement of technology throughout the last few decades has led to huge leaps forward in our ability to collaborate, produce, and multitask in the workplace. However, with the influx of new technologies, we are now capable of multitasking even to our own detriment.

  In order to generate more shots on goal in the development of a vaccine for COVID-19, the novel coronavirus that has become a global pandemic, the U.S. government will provide funds for the development of three vaccine programs against the disease. In an interview this morning

The modern workplace is made up of diverse groups of people from a variety of backgrounds who possess an eclectic mix of skills and interests. Gone are the days when everyone in an office tended to look and sound the same. Today, you will find

Your boss is a critical part of your everyday life. They have the authority to hire and fire, and they may dictate what work you do throughout the day. Because of this necessary and pivotal relationship, you want to have the best working partnership with

Since COVID-19 began its sweep across the United States, data has shown the disease caused by the novel coronavirus has disproportionately impacted racial and ethnic minority groups across the country. While there is no hard data as to why minority populations are more critically impacted,

Memorial Day is an American holiday, observed on the last Monday of May, honoring the men and women who died while serving in the U.S. military. Memorial Day 2020 occurs on Monday, May 25. Originally known as Decoration Day, it originated in the years following

More and more employers are using Skype interviews and other video interviews during their screening process. They may use a Skype interview in place of a phone interview, or after the phone interview before bringing you on-site.  Here are 10 tips to make a great first

Change is constant, it’s time we embrace it. Even better than just embracing it-learn to lead through it! You’ll have the advantage in the workplace and in the job market. In fact, employers today consider adaptability to be an essential on-the-job skill. Here are three

It can be too easy to construct a generic CV, especially if you’re just starting out. However, a generic CV is never the best way to deliver information to a recruiter, let alone to secure an interview. Job searching is all about quality, not quantity,

  If your career isn’t moving in the direction that you’d hoped and you find yourself dreading Monday’s it may be time to start looking for a new job. Here are 3 signs to look out for: You dread Monday mornings: Getting a knot in

While recruitment consultants can have an unfair reputation, the fact is, we really do get people jobs. You should think of a recruiter as your own personal brand ambassador; a person tasked with the sole objective of helping you take the next important step in

BioMarin Pharmaceutical is boosting its early-stage pipeline by penning a deal with Swiss startup Dinaqor. The deal, financials of which were not revealed, is a preclinical collab and license agreement that will see BioMarin tap into Dinaqor’s gene therapy platform, specifically to work on new

There was a lot of clinical trial news, much of it related to COVID-19, including promising data for Gilead Sciences’ remdesivir to treat the disease. There were also quite a few non-COVID-19-related trial updates as the industry continues working despite the global pandemic, presenting abstracts

  Google announced today new rules for the Chrome Web Store in an attempt to cut down the number of shady Chrome extensions submitted and listed on the site.The browser maker says that due to Chrome’s success as today’s top browser platform, the Chrome Web

With more than 70 groups worldwide rushing to develop a vaccine against COVID-19, including Moderna, Johnson & Johnson, Pfizer and BioNTech, Novavax and many others. One of the groups that appears to be ahead of the race isn’t a commercial biopharma company, but Oxford University’s

Today marks the 50th anniversary of Earth Day, an annual event which takes place across the world to raise awareness of problems affecting the environment. This year it comes in the wake of the coronavirus pandemic and the lockdowns which have impacted the globe –

via: https://www.biospace.com/article/roche-prepares-to-launch-covid-19-antibody-test-system Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been

via: https://www.techradar.com/news/the-best-free-products-and-services-to-help-your-business-navigate-the-coronavirus-crisis Free services are helping businesses mitigate the effects of the outbreak! Companies all over the world have ordered employees to work from home in response to the introduction of widespread quarantine and social distancing measures. Top of the list of concerns for many

via: https://xconomy.com/national/2020/04/14/gsk-and-sanofi-team-up-on-covid-19-vaccine-aim-for-clinic-this-year/ Pharmaceutical giants GlaxoSmithKline and Sanofi are teaming up on COVID-19 research, aiming to combine their respective technologies in a new vaccine that could start clinical trials in coming months. The full details of the agreement, which was announced Tuesday, are still being finalized. But

VIA – https://www.cadimensions.com/blog/3-ways-3d-printed-synthetic-body-parts-are-transforming-medical-device-companies Written by: Adam Fasnacht l Published in: 3D Printers If you work at a medical device company, you know that there are many situations that require using human body parts. More often than not, these come from cadavers and not 3D printed synthetic tissue.